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Abstract: Background - Current procedures for collection of human 
Amniotic Fluid Stem Cells (hAFSCs) imply that amniotic fluid cells were 
cultured in flask for two weeks, than can be devoted to research purpose. 
However, hAFSCs could be retrieved directly from a small amount of 
amniotic fluid that can be obtained at the time of diagnostic 
amniocentesis. The aim of the study was to verify if a direct freezing of 
amniotic fluid cells is able to maintain and / or improve the potential 
of the sub-population of stem cells. Methods - We compared the potential 
of the hAFSCs depending on the moment in which they are frozen, cells 
obtained directly from amniotic fluid aspiration (D samples) and cells 
cultured in flask before freezing (C samples). Colony-forming-unit 
ability, proliferation, morphology, stemness-related marker expression, 
senescence, apoptosis, and differentiation potential of C and D samples 
were compared. Results - hAFSCs isolated from D samples expressed MSC 
markers until later passages, had a good proliferation rate, and 
exhibited differentiation capacity similar to hAFSCs of C samples. 
Interestingly, the direct freezing induce a higher concentration of cells 
positive for pluripotency stem cell markers, without teratoma formation 
in vivo. 
Conclusions - This study suggests that minimal processing may be adequate 
for the banking of amniotic fluid cells, avoiding in vitro passages 
before the storage and exposure to high oxygen concentration affecting 
stem cell properties. This technique might be a reasonable approach in 
terms of costs and for the process of accreditation in GMP for a stem 
cell bank. 
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Dear Editor,  
 
We would like to thank the reviewers for the insightful and encouraging comments regarding 
our manuscript “DEVELOPMENT OF A NOVEL METHOD FOR AMNIOTIC FLUID 
STEM CELL STORAGE”. We have addressed all of the critiques as indicated  in the point-
by-point response below. All changes  have been marked using red font in the revised 
manuscript. 
Reviewer #1:  
 
1) After the sentence (introduction section,  pag 4)" Human amniotic fluid stem cells 
(hAFSCs) show all these characteristics." I suggest to add the following reference "Antonucci 
I, Provenzano M, Rodrigues M, Pantalone A, Salini V, Ballerini P, Borlongan CV, Stuppia L. 
Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases. Int J 
Mol Sci. 2016 Apr 22;17(4)" 
We thank the reviewer for all the suggestions, that we applied in the text. The reference has 
been added after that sentence with number [1]. 
2) It is important to specify in the paragraph"  Amniotic fluid collection " the number of 
amniotic fluid samples, the  mean  (±SD) maternal age  at  amniocentesis  and if all women 
showed normal fetal karyotypes. 
We added these clinical data to the M&M section as reported in this sentence: “The hAFSCs 
were obtained from 25 amniotic fluids collected from women (average age 36.3 ± SD 3.9) 
….and no one of the fetuses showed karyotype’s abnormality.” 
3) The crucial point of the manuscript is  the applicability/suitability of a direct freezing 
method of the amniotic fluid. The authors used for their experiments 4 ml of  amniotic fluid 
but  unfortunately in many laboratories are processed 2-3 ml of amniotic fluid .Is possible to 
obtain the same results with a lower amount of amniotic fluid? Authors should  discuss  this 
aspect 
The decision to collect 4 mL for the direct freezing method (D) was justified by the 
requirement to correctly compare with the C sample, obtained from 4 mL of fluid seeded in a 
T25 flask (25 cm
2
). In order to process 2-3 ml of amniotic fluid maintaining a similar ratio 
volume/area, a petri of 35 mm (9cm
2
) should be used. 
*Detailed Response to Reviewers
Click here to view linked References
This sentence has been added in “Amniotic fluid collection” section: “The fluid volume 
seeded in T25 of C samples by cytogenetic laboratory is of 4 mL, as well as the volume 
directly frozen, therefore the comparison between C and D samples is balanced. However it 
could be possible to store a minor volume of amniotic fluid, thawing in a smaller surface 
area.” 
 
 
Reviewer #2:  
This research allows interesting evidences on maintenance of multipotency capacity of 
hAFSCs obtained directly from amniotic fluid aspiration, as demonstrated by results 
presented in the manuscript, and support in general the conclusion discussed by the Authors. 
However in the data presented emerging some divergences of results that merit to be 
clarified. 
About the expression of CD44 in Figure 3A and 3B, the Authors referred the variability 
depending on the donor. If the sample D and C derived by the same donor, how the Authors 
explain the different expression of CD44 in lane 3 and 4 in WB investigation showed in 
Figure 3A despite the same level of actin? It would have expected a similar expression in the 
same sample but the image showed a downregulation of CD44 protein in a D sample (lane 3). 
To better support the results of flow cytometry in Figure 3B, the Figure 3A needs to be 
improved. It is reasonable that, if the direct storage technique of sample (sample D) proposed 
in the research does not change cells profile compared to sample C, it is not justified any 
differences in the two samples (D vs C) of the same donor. 
We thank the reviewer for the suggestion, therefore we decided to show a different image of 
western blot for CD44 (Figure 3 mod) that better reflects the graph of cytometric analysis. 
The analysis by Western blot was performed for 9 couples of samples, and only for one 
sample the intensity of CD44 was higher in C that in D sample (as showed in Figure 3A lane 
3 and 4), so in the new version of Figure 3A another set of patient has been shown. Indeed, 
the quantitative analysis by cytofluorimeter (and not only semi-quantitative as with WB) 
showed a clear (significant) trend, in particular for CD44, even with an evident error bar.  
Please, the Authors will better clarify the variability depending on donor in Result and 
Discussion Sections. 
The variability depending on the donor is an interesting point that we are trying to correlate 
with clinical data of the mother (smoke habit, gestosis, amniotic fluid volume, diabetic 
syndrome,…) and of the baby at birth (week of delivery, apgar score,…). We suppose that the 
intrinsic redox balance could have a role in this clue, as we demonstrated in Maraldi et al., 
“Nuclear Nox4 Role in Stemness Power of Human Amniotic Fluid Stem Cells” Oxidative 
Medicine and Cellular Longevity 2015 and Guida et al., “Inhibition of nuclearNox4 activity 
by plumbagin: effect on proliferative capacity in human amniotic stemcells,” Oxidative 
Medicine and Cellular Longevity. 2013. This last reference has been added. 
In fact it has been purposed that ROS homeostasis is an important modulator in stem cell 
power, independently on the age and the oxygen tension present during cultivation in vitro 
(this sentence has been added into the text). It has to be demonstrated if this redox status of 
AFSC (fetal cells), related to a minor stemness power, is linked to a specific anamnesis of the 
gestational ambient and if this observation could be related to an inclination to aging earlier 
in the adult life.  
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ABSTRACT  
Background - Current procedures for collection of human Amniotic Fluid Stem Cells 
(hAFSCs) imply that amniotic fluid cells were cultured in flask for two weeks, than can be 
devoted to research purpose. However, hAFSCs could be retrieved directly from a small 
amount of amniotic fluid that can be obtained at the time of diagnostic amniocentesis. The 
aim of the study was to verify if a direct freezing of amniotic fluid cells is able to maintain 
and / or improve the potential of the sub-population of stem cells. Methods - We compared 
the potential of the hAFSCs depending on the moment in which they are frozen, cells 
obtained directly from amniotic fluid aspiration (D samples) and cells cultured in flask before 
freezing (C samples). Colony-forming-unit ability, proliferation, morphology, stemness-
related marker expression, senescence, apoptosis, and differentiation potential of C and D 
samples were compared. Results - hAFSCs isolated from D samples expressed MSC markers 
until later passages, had a good proliferation rate, and exhibited differentiation capacity 
similar to hAFSCs of C samples. Interestingly, the direct freezing induce a higher 
concentration of cells positive for pluripotency stem cell markers, without teratoma formation 
in vivo. 
Conclusions - This study suggests that minimal processing may be adequate for the banking 
of amniotic fluid cells, avoiding in vitro passages before the storage and exposure to high 
oxygen concentration affecting stem cell properties. This technique might be a reasonable 
approach in terms of costs and for the process of accreditation in GMP for a stem cell bank. 
Keywords: AFSC, direct freezing; stem cell bank  
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Abbreviations: 
Human amniotic fluid stem cells (hAFSCs) Bovine serum albumin (BSA); 
carboxyfluorescein diacetate (CFDA); a colony-forming unit (CFU); cumulative population 
doubling (CPD); 1,4-diazabicyclo(2.2.2)octane (DABCO); 4',6-diamidino-2-phenylindole 
(DAPI); Ethylenediaminetetraacetic acid (EDTA); good manufacturing practice (GMP); 
immunofluorescence (IF); phosphate buffered saline (PBS); population doubling time (PDT); 
Tris-buffered saline (TBS); Triton–X-100 (TxTBS); western blot (WB). 
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Introduction 
The current effort in regenerative medicine is the use of human stem cells that are easy to 
collect, high proliferating, with large plasticity and without ethical issues. Human amniotic 
fluid stem cells (hAFSCs) show all these characteristics [1]. Moreover, hAFSCs are 
becoming an important biomaterial that may be used for cell therapy and tissue engineering 
applications also in perinatal medicine. The harvesting protocol of hAFSCs is well 
established in the clinical practice as well as the selection method, based on the c-kit surface 
marker expression [2]. Although the donor age range has to be considered quite restricted 
since the sample is usually obtained between the 16
th
 and the 20
th
 week of pregnancy, hAFSC 
samples may display different stemness properties depending on the donor [3], the gestational 
age [4] and the number of passages in culture [5]. Usually hAFSCs samples were cultured in 
flask in cytogenetic laboratories for two weeks, then can be devoted to research purpose, 
instead of being discarded. However this long time in culture, before the step of freezing and 
selection, may change the properties of the stem cells sub-population. 
In fact, at present, most of the cell expansion procedures are performed under atmospheric O2 
concentration (20% O2), which is approximately 4–10 times higher than the concentration of 
O2 in stem cell natural niches [6] that might cause environmental stress. Indeed, several 
studies have presented clear evidence regarding the negative influence of ambient O2 
concentration on stem cells, including longer population doubling time, early senescence, 
DNA damage [7,8], and poor engraftment following transplantation [9].  
The central aim of this project is to develop a new, easy to reproduce and good 
manufacturing practice (GMP) -compatible method to manage amniotic fluid collection in a 
stem cell bank. Indeed, hAFSCs can be retrieved directly from a small amount of amniotic 
fluid (3–5 mL) that can be obtained at the time of diagnostic amniocentesis. Theoretically, 
this amniotic fluid sample can be processed and stored in an optimized banking system, so 
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stem cells can be isolated or expanded at any time during the prenatal and post-natal period. 
This procedure is designed according to the current GMP legislation since it is easy, 
reproducible, inexpensive, and not susceptible to technical errors [10]. 
Therefore in this study we verify if a direct freezing of the amniotic fluid, taken at the time of 
amniocentesis, is able to maintain and / or improve the potential of the sub-population of 
stem cells. 
For this purpose, the proliferative rate during in vitro passages, before and after the selection 
process (based on c-kit antigen expression), has been analyzed by population doubling time 
calculation. The expression of surface mesenchymal markers for c-kit-positive cells was 
tested by immunofluorescence and Western blot approaches. Since hAFSCs are defined as 
intermediate between pluripotent and multipotent stem cells [11], the expression of 
pluripotency genes, such as Oct-4, Sox-2, Nanog, and SSEA-4, has been compared. 
Then, hAFSCs, deriving from the two storage methods (samples C and D), were induced to 
differentiate towards mesenchymal, endodermal and ectodermal lineages, in order to verify if 
the differentiation potential is comparable.  
 
MATERIAL AND METHODS 
Amniotic fluid collection 
The hAFSCs were obtained from 25 amniotic fluids collected from women (average age 36.3 
± SD 3.9) between the 16
th
 and 21
st
 week of gestation who undergo amniocentesis at 
Arcispedale S. Maria Nuova Hospital in Reggio Emilia. During the pre-amniocentesis 
interview pregnant women were informed about the purpose of the study and any risks 
related to. The informed consent were obtained, in accordance with the Italian law and the 
guidelines of the ethics committee (protocol 2015/0004362 of 02.24.2015). Informed consent, 
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as well as all documentation relating to the invasive procedure, were signed by the pregnant 
woman and by a specialist before continuing the exam.  
During the amniocentesis procedure 16 mL of fluid necessary for cytogenetic analysis are 
normally taken and put into 2 tubes of 10 mL; however, it is possible to increase the 
withdrawal of a few milliliters without affecting the health of the patient and fetus. Therefore, 
16 mL were used for diagnostic cytogenetic routine analysis (no one of the fetuses showed 
karyotype’s abnormality) and the additional 4 mL of amniotic fluid (D sample) were 
collected, encoded and treated with the GMP compatible cryoprotective medium (Cryostor 
CS10, STEMCELL Technologies) for freezing in liquid nitrogen. 
Subsequently, also the any supernumerary (unused) flask of AF cells (C sample) cultured in 
the Laboratory of Genetics Arcispedale S. Maria Nuova for 2 weeks were trypsinized and 
treated for freezing. Frozen cells obtained from the same patient (samples C and D) were then 
thawed (seeded in a T25 flask) and the comparison experiments has been performed. The 
fluid volume seeded in T25 of C samples by cytogenetic laboratory is of 4 mL, as well as the 
volume directly frozen, therefore the comparison between C and D samples is balanced. 
However it could be possible to store a minor volume of amniotic fluid, thawing in a smaller 
surface area.  
Adult Human Tissue isolation and cell culture  
Human amniotic fluid stem cells (hAFSCs) were isolated as previously described by De 
Coppi et al. 2007 [2]. Amniotic fluid cell cultures were harvested by trypsinization, and 
subjected to c-Kit immunoselection by MACS
®
 technology (Miltenyi Biotec, Germany). 
hAFSCs were subcultured routinely at 1:3 dilution and not allowed to expand beyond the 
70% of confluence. hAFSCs were grown in culture medium (AmnioChrome II) including an 
enriched basal medium and growth supplement (all from Lonza, Italy), since it is a medium  
used for the culture of human amniotic fluid cells obtained from amniocentesis. 
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Cell proliferation and colony-forming assays 
The proliferation rates of hAFSCs, from both C and D samples cryopreserved and stored for 
at most 1 year at -196°C, were analyzed. After reaching confluence, adherent cells, isolated 
as described above, were dissociated and seeded in T25 cm
2
 flask at a density of 2X10
3
 
cells/cm
2
, cultured for 3.5 days then detached, counted and seeded again at 2X10
3
 cells/cm
2 
concentration. All analyses were performed by individuals blinded to the experimental 
details. Cell density was expressed as the mean of cells/cm
2
 ± standard deviation (SD). 
Cultures were performed until passage 8. The following formula was applied to all samples 
for each experimental group (C and D): 
PD = [log10NH – log10NS]/ ÷ log102, where NS is the cell number at seeding (2 × 10
3
 
cells/cm
2
) and NH is the cell number at harvest. To calculate the cumulative number of 
population doublings (CPD), the PD determined for each passage was then added to the CPD 
of the previous passage. 
The population doubling time (PDT) was calculated in the phase of exponential growth by 
the following formula:  
PDT= log10(2)xT/log10(NH)-log10(N1d) 
where T represents the time between the cell harvesting and seeding, NH represents the 
harvested cell number and N1d represents the cell number at day 1. 
In order to evaluate the clonogenic potential, a colony-forming unit (CFU) assay was 
performed. hAFSCs samples C and D from passages 3 and 4, isolated from the same patient, 
were plated at 80 cells/cm
2
 and 160 cells/cm
2
 in 12-well polystyrene tissue culture plates and 
stored in basal culture medium for 7 days at 37° C in a 5% CO2 humidified atmosphere. The 
medium was then removed, and the cells were fixed with methanol/acetic acid 3:1 for 5 min, 
and stained with 0.5% crystal violet in methanol for 30 min at room temperature. A positive 
CFU was identified as an adherent colony containing at least 50 cells and was visualized at 
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10 magnification using a Nikon TE2000 inverted microscope. At the same time, a limiting 
dilution assay was performed, plating the cells at 250, 125, 62.5, 31, 16, 8, 4 , 2 and 1 
cells/well in a 96-well plate under the CFU assay conditions described above. After 10 days, 
the number of CFU colonies generated was counted. 
Senescence assay 
In order to evaluate the presence of senescent cells in hAFSCs of samples C and D, cells at 
passage 7-9 were seeded in 12-well plates and processed using a senescence β-Galactosidase 
staining kit (Cell Signaling, MA, USA), according to the manufacturer’s instructions. Six 
samples for each culture condition were analyzed, and the percentage of senescent cells 
calculated. 
Apoptosis assay 
hAFSCs (10
6
 cells) seeded on coverslips were washed with PBS. After three washes with 
binding buffer (10mM HEPES, pH7.5, containing 140mM NaCl and 2.5mM CaCl2), the 
specimen was incubated for 15min, with double staining solution (binding buffer containing 
Annexin V-Cy3 and CFDA), purchased from Sigma-Aldrich. At the end, the specimen was 
washed five times with binding buffer, mounted with 15μL of binding buffer and visualized 
under fluorescence microscopy. 
Oncogenic activity assay 
One million cells of three hAFSCs samples (C and D) at passage 4 (P4) and melanoma cells 
were detached and resuspended in PBS and mixed with Matrigel (Becton Dickinson) in a 1:1 
ratio. The suspended cells were injected in NOD SCID mice aged 8 weeks (Charles River 
Laboratoires, Lecco, Italy). All procedures were carried out according to the guidelines 
approved by the Committee of Use and Care of Laboratory Animals of the University of 
Modena and Reggio Emilia. 
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Animal care, maintenance and procedures were conducted in accordance with the Italian Law 
(D.L. No. 26/2014) and European legislation (2010/63/UE).  
Animals were sacrificed when the growth of a tumor mass was incompatible with the mouse 
well-being, usually 7 weeks, since a tumor mass was not palpable. 
For histological examination, tumors or the area of injection were surgically removed and 
fixed in 10% neutral-buffered formalin, dehydrated and embedded in paraffin. Serial section 
of 7 μm thickness were performed. Routine haematoxylin/eosin (H & E) staining was 
performed to analyze morphological details.  
Staining was performed also with DAB reaction after incubation with anti-human 
mitochondrial protein (Millipore, CA, USA) or anti-Ki67 (Santa Cruz, CA, USA) followed 
by secondary antibodies (Immunopure Thermo Scie., horseradish peroxidase conjugated,  
USA). Histological images were obtained with a Nikon Labophot-2 optical microscope 
equipped with a DS-5Mc CCD color camera (Nikon Instruments, Japan). 
Flow cytometer immune-assay 
hAFSCs derived from either C or D at first passage were sub-cultured until reaching 80% 
confluence. Following trypsin dissociation, cells were re-suspended in and confirmed, using 
flow cytometry, to meet the minimal criteria to be defined as MSCs, according to the 
standards established by the International Society for Cellular Therapy [12]. Cells were 
stained with the following antibodies (mAbs): Rabbit anti-Thy-1 (CD90) and Rabbit anti-
Endoglin (CD105) (Millipore, CA, USA); Mouse anti-SSEA4 (Cell Signaling, MA, USA); 
Goat anti-Integrin β1 (CD29), Rabbit anti-HCAM (CD44) (Santa Cruz CA, USA); Mouse 
anti-5’-Nucleotidase (CD73) (Gene Tex, CA, USA). 
The expression of surface markers was analyzed by indirect staining using secondary 
fluorochrome Alexa 488-conjugated antibodies (Abcam, Cambridge, UK). Non-specific 
fluorescence was assessed by using the secondary antibody alone. A minimum of 5,000 cells 
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per sample was acquired and analyzed using FACScan flow cytometer and Lysis II software 
(both from Becton Dickinson, San Jose, CA, USA).  
The same cell samples were analyzed for nuclear stem cell markers, such as Oct4 and Nanog 
(Cell Signalling, MA USA), after Fixation/Permeabilization process performed with the 
Staining Buffer Set (Miltenyi Biotec Inc, Auburn, CA, USA) optimized for nuclear staining. 
After exposure to the five differentiation media, nuclear differentiation markers, such as 
rabbit anti-Sox9 (Cell Signaling, MA, USA) and rabbit anti-PPAR (Santa Cruz, CA, USA) 
were analyzed by using the Staining Buffer Set (Miltenyi Biotec Inc, Auburn, CA, USA). 
Intracellular differentiation markers, such as rabbit anti-CK18, (Santa Cruz, CA, USA), goat 
anti-Aggrecan, rabbit anti-Collagen-II, mouse anti-Osteopontin, mouse anti-α-fetoprotein 
(Santa Cruz, CA, USA), and rabbit anti-β-Tubulin III (Millipore, CA, USA) were assessed 
after the FIX&PERM® Cell Fixation and Cell Permeabilization Kit (Life Technologies,MD, 
USA). 
Cell differentiation assays 
hAFSCs obtained from both C and D samples at passage 1 were tested for their ability to 
differentiate toward osteogenic, adipogenic, chondrogenic, hepatic and neurogenic lineages. 
For each differentiation experiment, at least 6 samples per condition were used. Cells were 
seeded at approximately 5X 10
3
 cells/cm
2
 on culture dishes and kept in culture medium until 
reaching sub-confluence. The medium was then replaced by differentiating media. 
Osteogenic differentiation was obtained after 3 weeks of culture in a classic osteogenic 
medium. Osteogenic medium was composed by culture medium supplemented with 100 µM 
2P-ascorbic acid, 100nM dexamethasone, 10mM β-glycerophosphate. The medium was 
changed twice a week. After 3weeks of osteogenic induction, extracellular calcium 
deposition by Alizarin red staining, and the expression of osteogenic markers were evaluated. 
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Chondrogenic differentiation was obtained after 3 weeks of culture in a medium containing 5 
% FBS, 100 nM dexamethasone, 10 ng/mL TGF β1 (Sigma-Aldrich, St.Louis, USA), 10 µM 
2P-ascorbic acid, 1% v/v of sodium pyruvate (Invitrogen, Italy), 50 mg/mL ITS premix (BD, 
Franklin Lakes, NJ, USA). 
Adipogenic differentiation. Cells were incubated for 3 weeks in adipogenic induction 
medium (culture medium supplemented with 0.5 mM isobutylmethylxanthine, 1 mM 
dexamethasone, 10 mM insulin, 200 mM indomethacin, and 10% FBS). Medium was 
changed twice a week. Lipid-rich vacuoles within the cells were evaluated by Oil red O 
staining and AdipoRed assay (LONZA, Basel Switzerland ), following the manufacturer’s 
instructions. 
Neurogenic differentiation occurred after 3 weeks in medium containing 20 µM retinoic acid 
[13]. Medium was changed twice a week. 
Immunofluorescence and confocal microscopy  
For immunofluorescence analysis, samples were processed as previously described. Confocal 
imaging was performed by a Nikon A1 confocal laser scanning microscope, as previously 
described [14]. Primary antibodies were raised against the following molecules: CK18, AFP, 
CD29, CD44, Aggrecan, Osteocalcin (Santa Cruz, CA, USA); CD90, RUNX2 (Abcam, 
Cambridge, UK); SSEA4 Collagen-II, TRA-1-81, GFAP, Oct4, Nanog and CNPase (Cell 
Signaling, MA, USA); CD73 (Gene Tex, CA, USA); CD105, β-Tubulin III (Millipore, CA, 
USA). 
The confocal serial sections were processed with ImageJ software to obtain three-
dimensional projections, as previously described. The image rendering was performed by 
Adobe Photoshop software.  
Western blotting  
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Whole cell lysates from hAFSCs were processed, as previously described [15]. Primary 
antibodies were raised against the following molecules: Nanog (Cell Signalling, MA, USA), 
Oct4, CD44, Sox2, CD29, β-actin (Santa Cruz, CA, USA), CD73 (Gene Tex, CA, USA) and 
CD105 (Millipore, CA, USA). 
Statistical analysis 
In vitro experiments were performed in triplicate. For quantitative comparisons, values were 
reported as mean ± SD (standard deviation) based on triplicate analysis for each sample. To 
test the significance of observed differences among the study groups Student’s t-test was 
applied. A P value <0.05 was considered to be statistically significant. 
 
Results 
Samples of 25 patients have been collected, stored and then thawed, expanded and selected 
for c-kit expression. The samples have been analyzed for proliferation rate, expression of 
pluripotent and mesenchymal markers and differentiation potential.  
Samples deriving from the direct collection protocol (D), being composed of a small cell 
number, need around 7 days to start to growth in culture, since only few cell colonies begin to 
attach and expand during the first week. Therefore a time of 10-14 days is necessary to obtain 
a cell number comparable to the one of C just thawed. This data is not surprising since C 
samples derive from 2 weeks in culture. It is noteworthy that, both for C and D samples, only 
a minor cells number attach and create the cell culture, suggesting an intrinsic selection of a 
subpopulation.  
Regarding the proliferation rate after the c-kit selection, the two samples grow in a similar 
manner, as shown in Fig. 1A and B. The graph of Fig. 1A shows the cumulative population 
doubling (CPD) curves obtained expanding representative hAFSCs samples, derived from C 
or D collection methods, during several passages in culture. The growth rate is similar and 
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the two lines overlap, since the numbers of cells at the first passage were analogous as well as 
the curve slopes. It is noticeable that, for a number of donors, the curve does not begin to sag 
still at passage 7. The second graph (Fig 1B) shows all the values of population doubling time 
(PDT) obtained from C and D samples at passage 2, displaying that there is not a significant 
difference between the average of C and D, but highlights that there is a variability among the 
donors, since not all the points are concentrated close to the average. 
The clonogenic capacity of C and D samples are shown in Fig. 1 C,D where the first graph 
displays the number of colony forming unit (CFU) obtained after 10 days depending on the 
cell seeded density: where the initial cell concentration was 80 cells/cm
2
 the number of 
colonies is comparable, while at 160 cells/cm
2
, the D samples produce a higher CFU number. 
On the other hand, the second graph, showing the capacity to generate at least one colony 
starting from 1 or 2 seeded cells, indicates a better performance for C sample.  
The viability of hAFSCs was evaluated with a combined test that highlights the presence of  
apoptotic cells with a probe for AnnexinV, and the level of cell metabolism, related to the 
viability, with CFDA probe (Fig. 1E). The intensity of green fluorescence (CFDA) is 
comparable between C and D samples, as well as the number of red cells (AnnexinV), while 
the sample incubated with staurosporin (St), inducing apoptosis, shows a decrease in green 
fluorescence and cells with a red ring are detectable.  
The culture in vitro has been performed for 1 month for all the samples, and, particularly for 
some donor, the growth curve displayed a decrease in the proliferation rate stating from the 
4
th
 passage, as shown in Fig. 1F. Therefore the senescence grade of C and D samples has 
been compared, analyzing the beta-galactosidase activity. Images of Figure 1F are 
representative of the beta-galactosidase assay: the blue staining, indicating senescent cells, is 
similar for the C and D samples. 
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The mesenchymal and pluripotent stem cell markers analysis was performed with 
immunfluorescence (IF), Western blot (WB) and cytofluorimetric experiments looking at 
CD-44, CD-29, CD-73, CD-90, CD-105, SSEA4, TRA-1-81, Oct4, Nanog and Sox2. Figure 
2A-C includes data regarding the pluripotent profile of hAFSCs derived from direct or 
indirect collection (D and C samples) and analyzed at second passage in culture. 
Interestingly, the performed quantitative and semi-quantitative analysis clearly displays a 
significant higher expression of Oct4, Nanog and Sox2 in D samples, rather than in C 
samples, suggesting the maintaining of a superior stemness capacity thanks to the direct 
collection protocol.  
Since the high expression of embryonic markers, such as Oct4, Nanog and Sox2, could be 
related to teratogenic capacity, a oncogenic test in vivo was performed. One million of 
hAFSCs, seeded in hydrogel (matrigel), were subcutaneously injected in immunosuppressed 
mice and the formation of a palpable mass and the mice weight were monitored for 2 months. 
In hAFSCs treated mice the presence of a mass was not detectable and there was not a 
decrease in the body weight, unlike in positive control mice, injected with a melanoma cell 
line. Figure 2D shows that in the area of injection cells of human origin are still present, 
forming a loose connective -like tissue, without a high proliferative activity. 
No differences between C and D have emerged regarding mesenchymal markers, except for 
CD44 protein that is more expressed in D samples, as demonstrated by flow cytometry (Fig. 
3B). Qualitative and semi-quantitative experiments, such as IF and WB of Fig. 3A and C 
respectively, did not reveal any variability. On the other hand, we noticed that there is a 
variability depending on the donor, as already demonstrated for proliferation parameters.  
We then tested the potential of differentiation into mesodermal (osteo, chondro and 
adipogenic), endodermal (hepatic) and ectodermal (neurogenic) lineages. For this purpose 
hAFSCs (C and D samples) were exposed for 3 weeks to the appropriate media of 
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differentiation and further the expression of protein markers of various tissues were evaluated 
with IF and flow cytometry, as shown in Fig. 4, 5 and Table I. For instance, cytokeratin 18 
and alpha fetoprotein for hepatic differentiation, tubulin III, GFAP and CNPase for 
neurogenic, osteocalcin, osteopontin and RUNX2 for osteogenic, PPAR for adipogenic and 
Sox9, aggrecan and collagen II for chondrogenic. Additionally, alizarin red staining has been 
used to reveal the mineralized matrix in osteogenic differentiation and red oil staining to 
demonstrate lipid drops in the adipogenic one. Immunofluorescence and histological 
investigation shows the capability for both the AFSC sample groups to differentiate in tissues 
deriving from all the three germ layers, but the analysis of quantitative data (Table I) did not 
reveal a clear imbalance in the differentiation capacity of C and D samples.  
 
Discussion 
MSCs are a highly relevant stem cell population for clinical applications due to their 
multilineage differentiation potential, immunomodulatory effects, and ability to home to sites 
of inflammation [16,17]. However, while many clinical trials currently use MSCs, the rarity 
of these cells - regardless of source - require vigorous ex vivo expansion prior to clinical use. 
Such expansion will cause replicative senescence, which limits MSC number for subsequent 
utilization or adversely alters MSCs functional capacity and therapeutic effects [18]. 
Concentration of MSCs within tissues is very low, regardless the origin, and it is not possible 
to isolate 50–200 million MSCs (typically used in clinical trials) from a donor for each 
therapy. Thus, in vitro expansion of MSCs has become an inevitable option [19]. 
Cellular senescence is the state of permanent inhibition of cell proliferation due to the 
telomeres shortening and leads to DNA damage. Oxidative stress is known to play a role in 
stem cell self-renewal and differentiation and several research groups have shown the 
relationship among oxidative stress level and both proliferative capacity and senescence of 
16 
 
stem cells [20]. To improve cell therapy efficacy, it is therefore necessary to modulate MSCs 
in order to enhance their survival upon ex vivo manipulation insults such as oxidative stress. 
Since counteracting cellular senescence could prolong the proliferative capacity of stem cells, 
strategies to overcome the stemness decline are essential [21]. 
Another main challenge for regenerative therapy is to develop an easy, reproducible and fast 
cryopreservation protocol that allows long-term storage without affecting the characteristics 
of the cells, thus encouraging the realization of public stem cells banks and allowing their 
clinical application. 
This project is focused on human amniotic fluid as stem cell source, since amniotic fluid stem 
cells (hAFSCs) are easy to collect, highly proliferating, with large plasticity and without 
ethical concerns. Stem cells derived from the amniotic fluid are a new source of cells that 
may have therapeutic value for various diseases of pre- and post-natal life. Transplantation in 
uterus is used to treat congenital disorders in the fetus using cells capable of self renewal that 
can augment or replace the organ in the fetus [22]. The advantages of autologous transplants 
include a low incidence of rejection and infections and eliminate the need for external 
compatible donor recruitment. 
Here we reported for the first time the applicability/suitability of a direct freezing method of 
cells of amniotic fluid, avoiding in vitro passages before the storage, so maintaining the GMP 
guidelines. This could represent a reasonable approach to store stem cells contained in 
amniotic fluid in a stem cell bank for clinical purpose in parallel to the storage of the same 
fluid amount, that may be a rich source of soluble factors or extracellular vesicles potentially 
interesting for clinical diagnosis or regenerative therapy [23]. This technique might be 
convenient both in terms of costs, with regard to the materials for the in vitro cultures used 
earlier than necessary, but also for the process of accreditation in GMP which would be 
required for the steps of in vitro expansion. 
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The stem cell culture profile obtained from the direct collection of amniotic fluid (D samples) 
has been tested on cells during several passages in culture analyzing the growth rate, the 
capability to form colonies, the major phenotypes of premature aging, including premature 
loss of proliferative potential, increased number of senescence-associated–β galactosidase 
(SA-β-gal)–positive cells. Comparing with data obtained from the stem cell cultures isolated 
after expansion and cryopreservation (C samples), we did not observe relevant differences, 
regarding the viability, proliferation capacity and in term of number of senescent or apoptotic 
cells. The analysis of clonogenic activity showed divergent data. Although both the samples 
(C and D) were able to form a colony starting from 1 cell/well (limit dilution), demonstrating 
this capability related to stemness, D samples displayed a better performance only if seeded 
at higher concentration, suggesting that the stem cell subpopulation obtained with this 
methods could grow faster if seeded at this experimental density. 
Linked to this observation could be the data shown in Figure 2 where D samples display a 
higher expression of markers of pluripotency, such as Oct4, Sox2 and Nanog. These proteins 
regulate self-renewal and pluripotency in human embryonic stem (hES) cells. Transplantation 
of hES cells into immune-deficient mice leads to the formation of differentiated tumors 
comprising all three germ layers, resembling spontaneous human teratomas. In order to 
exclude this huge side effect, we tested the potency of teratoma formation in subcutaneous 
space in immune-compromised mice with addition of Matrigel, and we did not found the 
presence of cyst after 8 weeks, but only a little loose connective tissue presenting human cells 
expressing low level of Ki67. Ki-67 is a nuclear protein being associated with cellular 
proliferation, and Ki-67 positivity confers a poor prognosis of tumor progression. These 
observations demonstrate that hAFSCs, obtained with the direct method, can maintain the 
expression of pluripotency-regulating transcription factors without inducing teratoma 
formation in vivo. 
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hAFSCs expressing Oct4, Nanog, Sox2 are positive also for other stem cell markers, such as 
SSEA4 [24], and share with BM-MSCs the expression of the mesenchymal surface markers 
CD29, CD44, CD73, CD90 and CD105 [25]. The quantitative analysis shows that D samples 
express a significant higher level of CD44, than C samples, but, even if not statistically 
significant, also cells positive for CD29, CD73 and CD105 are more abundant in D samples. 
Looking at CD44 or homing cell adhesion molecule (HCAM), it functions in cell adhesion, 
migration, homing, proliferation and apoptosis of stem cells and have role in stemness 
maintenance by involving in contact between stem cells/progenitor cells and their cellular 
niche [26]. The fact that the percentage of positive cells for the essential mesenchymal 
markers (CD105, CD73 and CD90) are less than 95%, is due to the heterogeneity of this stem 
cells population [24]. The width of error bar is due to the donor variability, also shown in the 
Western Blot analysis (Fig. 3A), that is a critical point to be investigated one by one, in order 
to find a correlation between the hAFSCs profile and the physio-pathological feature of the 
donor. We purpose that an intrinsic ROS homeostasis, depending on specific ROS sources, is 
an important modulator in stem cell power, independently on the age and the oxygen tension 
present during cultivation in vitro [3, 27]. 
The efficiency in differentiation towards mesenchymal lineages has been compared and 
histological results obtained for adipogenic and osteogenic markers, such as lipid droplets 
and calcium deposition respectively, suggest that D samples are more prone to be committed 
into cells of bone and adipose tissues. Also the quantitative assay indicates that PPAR, as a 
member of the nuclear receptor superfamily that promote adipogenesis, is more expressed in 
D samples. Runx2 plays an essential role upstream of osteoblastic differentiation, therefore a 
high Runx2 expression appears in early stage of osteogenic induction, but Runx2 expression 
reduces significantly during the differentiation into mature osteoblast, and Runx2 is 
undetectable during the differentiation into osteocytes [28]. Indeed IF data shows that Runx2 
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is still expressed into nuclei of C cells, suggesting a delay in the differentiation process, if 
compared to D samples. Chondrogenic differentiation seems to develop in similar manner for 
both the cell samples as well as for endodermal and ectodermal differentiation, when we 
tested the hepatogenic and neural induction, including neuronal and glial cyto-types.  
In conclusion, the purpose to cryopreserve amniotic fluid cells separated from the same fluid 
would be more practical than direct primary isolation of stem cells, which requires further 
toilsome, time-consuming, and expensive processes, especially while employing current good 
manufacturing practice (GMP) standards for clinical use of the cells. Hence, cryopreservation 
of amniotic fluid cells (including the fluid) for afterwards isolation and expansion may be 
favorable for the banking of specimens not immediately needed and then allows to carry out 
cell cultures and pre-differentiation with low oxygen concentration only in case of therapy 
requirement. In fact cells can normally defend themselves against reactive oxygen species 
(ROS) damage through the use of specific enzymatic or non-enzymatic mechanisms. 
However, the response of stem cells to oxidative stress is not well understood but it has been 
related to increased rates of aneuploidy, double-stranded DNA breaks, and faster telomere 
shortening for MSCs cultured in ambient condition [7]. Furthermore, this study provides new 
knowledge for optimization of the cryopreservation process and subsequent thawing, and to 
increase the replicative potential of this biological material in order to obtain sufficient 
quantities of hAFSCs to be successfully used in clinical practice. 
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Table I – Cytofluorimetric analysis of differentiation marker expression 
 
 
 
 
 
 
 
 
hAFCSs from 4 samples C and D were exposed to differentiating media for 3 weeks then 
analyzed for differentiation markers (Osteopontin, SOX9 and Collagen 2, PPAR, Cytokeratin 
18 and β-tubulinIII for osteogenic, chondrogenic, adipogenic, hepatic and neurogenic 
differentiation, respectively). The percentage of positive cells is shown. At least 8000 cells 
were evaluated for each cytofluorimetric analysis. 
 
 
  
 
 
Ab D C 
OPN 61±3 63±5 
SOX9 10±4 14±2 
Coll 2 19±3 16±3 
PPAR 54±6 46±5 
CK18 20±3 18±1 
Tub III 59±5 68±6 
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Legends to the figure 
 
Figure 1. hAFSCs derived from direct (D) or indirect (C) collection protocol: comparison of 
the proliferation capability. A) The graph, representative of most of the samples, shows the 
cumulative population doubling (CPD) calculated until the 7
th
 passage in culture. No 
differences in the two curves are evident. B) Population doubling time (PDT) values of all C 
and D samples, evaluated at the second passage in culture. The average values are not 
significantly different. C) The graph compares the number of colony forming units (CFU) 
obtained from C and D samples seeded at different density: only in the case of 160 cell/cm
2 
D 
samples display a significant higher value (* P0.05). D) Percentage of well presenting at 
least one colony after 10 days of culture of hAFSCs (C and D samples) seeded at the density 
of 1 or 2 cells/well. E) Apoptotic cells in C and D samples: representative 
immunofluorescence (IF) images of CFDA (green), indicating the viability of the cells, 
Annexin V (red), showing apoptotic cells, labelling of exposed hAFSCs alone or exposed to 
staurosporin (St) for 4 hours, as positive control. Bar=20 µm. F) Graph showing the CPD of 
C and D samples of a donor that, starting from the 4
th
 passage, displays a decrease in the 
growth rate. Representative images of beta-galactosidase assay performed in C and D 
samples. Senescent cells are blue stained. Bar=20 µm. 
Figure 2. Pluripotent capability of C and D samples of hAFSCs. A) Western Blot analysis 
revealed with anti-Oct4, anti-Nanog and anti-Sox2 of total lysates of hAFSCs (C and D 
samples) at passage 2. Actin detection was performed in order to show the amount of protein 
loaded in each lane. Presented data are representative of three independent experiments. The 
graph shows densitometric analysis of Western Blot experiments (*** P0.0001). B) 
Representative confocal images of C and D hAFSCs at passage 2 labelled with DAPI (blue) 
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and anti-Oct4 (green). Bar=10 µm. C) Graph showing the cytofluorimetric analysis of Nanog 
expression: C sample (red curve) displays 58 % of positive cells, while D sample (blue curve) 
89 %. The black curve is related to the sample of cells incubated only with secondary 
antibody, as negative control. D) Histological examination of subcutaneous tissue derived 
from the area of injection of D cells in immunocompromised mice sacrificed after 8 weeks. 
The first image, stained with hematoxylin and eosin (H&E), shows abundant extracellular 
matrix with a moderate cell density. DAB reaction for revealing human cells presence, by 
antibody selective for human mitochondrial protein (HMit), and proliferating cells, by 
antibody for Ki67. Brown staining indicates positive cells. Bar=200 µm.   
Figure 3. Mesenchymal profile of C and D samples of hAFSCs. A) Western Blot analysis 
revealed with anti-CD44, anti-CD73, anti-CD29, anti-CD105 and anti-CD90 of total lysates 
of three hAFSCs C and D samples at passage 2. Actin detection was performed in order to 
show the amount of protein loaded in each lane. B) Quantitative analysis by flow cytometry 
of the expression of CD44, CD73, CD29, CD105, CD90 and SSEA-4 proteins. The 
comparison between C and D samples shows a significant difference only for CD44 (* 
P0.05). C) Representative confocal images of three samples of C and D hAFSCs at passage 
2 labelled with DAPI (blue), anti-CD29, -CD105, -CD90 (green) and anti-SSEA-4, -CD44, -
CD73 (red). Bar=10 µm. 
Figure 4. Differentiation capability of C and D hAFSCs samples into mesenchymal lineages. 
A) Osteogenic differentiation after three weeks of exposure to osteogenic medium. 
Evaluation of calcium deposition in the extracellular matrix through Alizarin Red staining: 
the intensity of red staining is related to the calcium presence typical of mineralizing tissue. 
Bar=100 µm. Representative confocal images of C and D hAFSCs labelled with DAPI (blue), 
anti-osteocalcin (OCN) in green and anti-Runx2 in red. Bar=10 µm. B) Chondrogenic 
differentiation. Representative confocal images of C and D hAFSCs labelled with DAPI 
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(blue), anti-collagen II (Coll2) in green and anti-aggrecan (Aggr) in red. Bar=10 µm. C) 
Adipogenic differentiation. Evaluation of intracellular lipid droplets through Red oil staining: 
the intensity of red staining is related to the lipid droplet presence typical of adipocytes. 
Bar=100 µm. 
Figure 5. Differentiation capability of C and D hAFSCs samples into endodermal and 
ectodermal lineages. A) Hepatic differentiation. Representative confocal images of C and D 
hAFSCs labelled with DAPI (blue), anti-cytokeratin 18 (CK18) in green and anti-
alphafetoprotein (AFP) in red. B) Neurogenic differentiation. Representative confocal images 
of C and D hAFSCs labelled with DAPI (blue), anti- Glial fibrillary acidic protein (GFAP) 
and anti-2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in green and anti-beta tubulin 
III (Tub III) in red. Bar=10 µm. 
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